Bradley JS, Norice CT, Roilides E, Shevelev A, et al. Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections. Pediatr Infect Dis J 2026 Jul 7. doi: 10.1097/INF.0000000000005323.
PMID: 42400209